These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26924356)

  • 21. Inverse gas chromatography: investigating whether the technique preferentially probes high energy sites for mixtures of crystalline and amorphous lactose.
    Newell HE; Buckton G
    Pharm Res; 2004 Aug; 21(8):1440-4. PubMed ID: 15359579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of inverse gas chromatography for the study of lactose and pharmaceutical materials used in dry powder inhalers.
    Jones MD; Young P; Traini D
    Adv Drug Deliv Rev; 2012 Mar; 64(3):285-93. PubMed ID: 22265843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces.
    Zhou QT; Morton DA
    Adv Drug Deliv Rev; 2012 Mar; 64(3):275-84. PubMed ID: 21782866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly loaded interactive mixtures for dry powder inhalers: prediction of the adhesion capacity using surface energy and solubility parameters.
    Wagner KG; Dowe U; Zadnik J
    Pharmazie; 2005 May; 60(5):339-44. PubMed ID: 15918581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profoundly improving flow properties of a cohesive cellulose powder by surface coating with nano-silica through comilling.
    Chattoraj S; Shi L; Sun CC
    J Pharm Sci; 2011 Nov; 100(11):4943-52. PubMed ID: 21698602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of particle characteristics to elucidate mix homogeneity in binary powder blends.
    Vachon MG; Chulia D
    Drug Dev Ind Pharm; 1998 Oct; 24(10):961-71. PubMed ID: 9876551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of fines on the surface energy heterogeneity of lactose for pulmonary drug delivery.
    Ho R; Muresan AS; Hebbink GA; Heng JY
    Int J Pharm; 2010 Mar; 388(1-2):88-94. PubMed ID: 20038447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Powder compression mechanics of spray-dried lactose nanocomposites.
    Hellrup J; Nordström J; Mahlin D
    Int J Pharm; 2017 Feb; 518(1-2):1-10. PubMed ID: 28007544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of carrier surface fines on dry powder inhalation formulations.
    Boshhiha AM; Urbanetz NA
    Drug Dev Ind Pharm; 2009 Aug; 35(8):904-16. PubMed ID: 19466888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of particle morphology on the physical stability of pharmaceutical powder mixtures: the effect of surface roughness of the carrier on the stability of ordered mixtures.
    Swaminathan V; Kildsig DO
    Drug Dev Ind Pharm; 2000 Apr; 26(4):365-73. PubMed ID: 10769777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of powder flow properties on capsule filling weight uniformity.
    Osorio JG; Muzzio FJ
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1464-75. PubMed ID: 23902366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Int J Pharm; 2006 Dec; 327(1-2):17-25. PubMed ID: 16920287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
    Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
    J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of pharmaceutical powder blends by NIR chemical imaging.
    Ma H; Anderson CA
    J Pharm Sci; 2008 Aug; 97(8):3305-20. PubMed ID: 17948913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of glidants: investigation of the effect of different colloidal silicon dioxide types on powder flow by atomic force and scanning electron microscopy.
    Jonat S; Hasenzahl S; Gray A; Schmidt PC
    J Pharm Sci; 2004 Oct; 93(10):2635-44. PubMed ID: 15349972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of carrier on the performance of dry powder inhalers.
    Saint-Lorant G; Leterme P; Gayot A; Flament MP
    Int J Pharm; 2007 Apr; 334(1-2):85-91. PubMed ID: 17113733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse gas chromatography: considerations about appropriate use for amorphous and crystalline powders.
    Planinsek O; Buckton G
    J Pharm Sci; 2003 Jun; 92(6):1286-94. PubMed ID: 12761817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.